Rain Therapeutics Inc. (NASDAQ: RAIN) reported Q1 EPS of ($0.56), $0.06 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Rain Therapeutics Inc. (RAIN) click here.